27mon MSN
Legal questions swirl around FDA’s new expedited drug program, including who should sign off
A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been rocked by recent layoffs and resignations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback